Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.

scientific article published in April 2007

Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JMRI.20873
P698PubMed publication ID17335040
P5875ResearchGate publication ID6471797

P50authorMaximilian ReiserQ15439977
Stefan O. SchoenbergQ88712387
P2093author name stringThomas Helmberger
Christoph J Zech
Sook Namkung
P2860cites workPreoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT.Q33882345
Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.Q34049777
Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imagingQ36855570
Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imagingQ43636090
Hepatic lesion detection at MR imaging: a comparative study with four sequences.Q52868020
Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.Q52912689
P433issue4
P304page(s)755-765
P577publication date2007-04-01
P1433published inJournal of Magnetic Resonance ImagingQ15761156
P1476titleSuperparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
P478volume25

Reverse relations

cites work (P2860)
Q89060389A perspective on a rapid and radiation-free tracer imaging modality, magnetic particle imaging, with promise for clinical translation
Q55516366Application of Light Scattering Techniques to Nanoparticle Characterization and Development.
Q37868455Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches.
Q85118876Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging
Q36110641Evaluation of the uptake function of liver in rats with obstructive jaundice before and after relief from obstruction by superparamagnetic iron oxide-enhanced magnetic resonance imaging
Q48544742MRI monitoring of monocytes to detect immune stimulating treatment response in brain tumor.
Q39038645New carboxysilane-coated iron oxide nanoparticles for nonspecific cell labelling.
Q36324508Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI.
Q50217177Simultaneous detection of hepatocellular carcinoma and vessel thrombus by using SPIO-enhanced B-TFE with the T2 preparation pulse technique
Q42136590Sudden cardiac death in a patient with advanced hepatocellular carcinoma with good response to sorafenib treatment: A case report with literature analysis
Q38425098Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.
Q87140224[Incidence of non-metastatic liver lesions in tumor patients: consequences for chemotherapy and local ablative procedures]

Search more.